Market Overview

The Global Dengue Testing Market was valued at USD 624.1 million in 2023 and is expected to reach USD 1,048.5 million by 2031 while growing at a CAGR of 6.7% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global dengue testing market growth. Dengue testing involves diagnostic techniques aimed at detecting the presence of the dengue virus or antibodies produced by the immune system due to infection. Transmitted mainly by Aedes mosquitoes, dengue is a viral disease posing a substantial public health threat in numerous tropical and subtropical areas globally.

The increasing dengue cases and advancements in testing methods like RDTs, NAATs, and serological tests boost the dengue testing market. Yet, cost constraints and limited healthcare access may hinder its growth.

Furthermore, the global dengue testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Type Analysis

The Global Dengue Testing Market is segmented among ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Other Tests, based on Product. In 2023, ELISA-based Tests accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By End User Analysis

The Global Dengue Testing Market is segmented among Hospitals, Diagnostic Centers, and Other End Users, based on End User. In 2023, Hospitals accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Dengue Testing Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abbott Laboratories, Abnova Corporation, PerkinElmer Inc (Euroimmun AG), Certest Biotec SL, Diasorin, F. Hoffmann-La Roche Ltd, InBios International Inc., NovaTec Immundiagnostica GmbH, OriGene Technologies, and Thermo Fisher Scientific Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Dengue Testing Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Dengue Testing Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Dengue Testing Market Segmentation, By Product

• Global Dengue Testing Market Share Analysis, By Product

• Global Dengue Testing Market Growth Analysis, By Product

• Global Dengue Testing Market Trends, By Product

o ELISA-based Tests

o RT-PCR based Tests

o Dengue IgG/IgM Rapid Test

o Other Tests

6. Global Dengue Testing Market Segmentation, By End User

• Global Dengue Testing Market Share Analysis, By End User

• Global Dengue Testing Market Growth Analysis, By End User

• Global Dengue Testing Market Trends, By End User

o Hospitals

o Diagnostic Centers

o Other End Users

7. Global Dengue Testing Market Segmentation, By Region

• Global Dengue Testing Market Share Analysis, By Region

• Global Dengue Testing Market Growth Analysis, By Region

• Global Dengue Testing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Abbott Laboratories*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Abnova Corporation

• PerkinElmer Inc (Euroimmun AG)

• Certest Biotec SL

• Diasorin

• F. Hoffmann-La Roche Ltd

• InBios International Inc.

• NovaTec Immundiagnostica GmbH

• OriGene Technologies

• Thermo Fisher Scientific Inc.

*Similar analysis will be provided for each company listed above.